Milestone Scientific (MLSS) introduces CompuFlo epidural system

Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the commercial implementation of its CompuFlo® Epidural System at Pain Doctors Medical LLC, a specialized interventional pain management center. This rollout follows a successful evaluation led by Dr. Ilana Etelzon, MD, a board-certified expert in Interventional Pain Management and Physical Medicine & Rehabilitation Medicine, who has integrated the technology into her practice to enhance patient safety and procedural efficiency.

The CompuFlo® Epidural System uses Milestone Scientific’s proprietary Dynamic Pressure Sensing Technology® to provide real-time verification of epidural needle placement. This precision-driven approach improves safety and reduces the risk of complications, allowing for greater confidence in pain management procedures.

Dr. Etelzon commented, “The CompuFlo® Epidural System represents a significant advancement in epidural administration. The ability to confirm needle placement with real-time feedback not only enhances procedural accuracy but also provides peace of mind for both physicians and patients. Integrating this technology into my practice at Pain Doctors Medical LLC allows us to deliver safer and more effective pain management solutions.”

This launch follows the recent Medicare price assignment for the CompuFlo® Epidural System, which is helping drive broader accessibility across interventional pain management and rehabilitation centers. With a strong track record of clinical validation, the system is increasingly being recognized as an essential tool for improving patient care.

Neal Goldman, Chairman and Interim Chief Executive Officer of Milestone Scientific, added, “Expanding our reach within interventional pain management centers like Pain Doctors Medical LLC is a crucial step in broadening the reach of our CompuFlo® technology. Dr. Etelzon’s positive experience with the system reaffirms its clinical benefits, and we are committed to furthering its adoption across leading pain management providers. As reimbursement coverage continues to strengthen, we anticipate accelerating growth within this sector.”

You May Also Be Interested In